Frontlight ResearchEarly access
Trial site
Muhlenkreiskliniken AöR
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Melanoma4 trials
- Childhood cancers3 trials
- Acute myeloid leukaemia2 trials
- Myelodysplastic syndromes2 trials
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Hodgkin lymphoma1 trial
- Metastatic breast cancer1 trial
- Stroke1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 39 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Completed3 trials
- Lead sponsor
- Merck Sharp & Dohme LLC2 trials
- AstraZeneca1 trial
- Bristol-Myers Squibb1 trial
- GlaxoSmithKline1 trial
- Immunocore Ltd1 trial
- and 5 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma2 recruiting
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Hodgkin lymphoma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
Clinical trial of MK-7648A in adults and children with skin cancer
Completed
Active, not recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026